Patent AnalyticsExaminers
Menu

Application

15037381 · ORAL DISPERSIBLE COMPOSITION OF A DPP-IV INHIBITOR

Filed 2016-05-18 · Abandoned The official file ↗ · Art unit 1611 · Examiner Kyle A Purdy Typical · CPC A61K 31/4985 · RANBAXY LABORATORIES LIMITED · Sun Pharma

Office actions
2
first was Non-final rejection
RCEs
0
no appeal
To first action
8.8 mo
to disposition 22.6 mo
Statutes raised
102 103
2 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in